StockData
Merck & Co., Inc. logo

Merck & Co., Inc. (MRK) operating KPIs

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)

Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%

Merck pP&E — Construction in Progress ($M) ($M)

Postgres DB financial_values

Latest, FY2025
9,166
Period ended Dec 31, 2025
Change on a year earlier
+14.8%
7,984 in FY2024
History
18 years
Since FY2008
Sources
16
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedPP&E — Construction in Progress ($M) ($M)Year on yearSource
FY2025Dec 31, 20259,166+14.8%Form 10-K (filed 2026-02-24) ↗
FY2024Dec 31, 20247,984-3.4%Form 10-K (filed 2025-02-25) ↗
FY2023Dec 31, 20238,262-10.1%Form 10-K (filed 2024-02-26) ↗
FY2022Dec 31, 20229,186+10.5%Form 10-K (filed 2023-02-24) ↗
FY2021Dec 31, 20218,313+19.3%Form 10-K (filed 2022-02-25) ↗
FY2020Dec 31, 20206,968+39.0%Form 10-K (filed 2022-02-25) ↗
FY2019Dec 31, 20195,013+49.4%Form 10-K (filed 2020-02-26) ↗
FY2018Dec 31, 20183,355+45.8%Form 10-K (filed 2019-02-27) ↗
FY2017Dec 31, 20172,301+23.0%Form 10-K (filed 2018-02-27) ↗
FY2016Dec 31, 20161,871+22.7%SEC Filing ↗
FY2015Dec 31, 20151,525+5.3%Form 10-K (filed 2016-02-26) ↗
FY2014Dec 31, 20141,448-20.0%Form 10-K (filed 2015-02-27) ↗
FY2013Dec 31, 20131,811-25.8%Form 10-K (filed 2014-02-27) ↗
FY2012Dec 31, 20122,440+11.0%Form 10-K (filed 2013-02-28) ↗
FY2011Dec 31, 20112,198+6.4%Form 10-K (filed 2012-02-28) ↗
FY2010Dec 31, 20102,066+13.6%Form 10-K (filed 2011-02-28) ↗

Cite this data

StockData. (2026). Merck PP&E — Construction in Progress ($M) ($M), annual FY2008–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/db_bal_ppe_cip

See every metric in the Merck KPI table. Data updated Oct 26, 2026.